Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Lack of KIR4.1 autoantibodies in Japanese patients with MS and NMO.
Products
[Exogenous evoked potentials in adolesccents with muftiple sclerosis].
Overexpression of Tau Rescues Nogo-66-Induced Neurite Outgrowth Inhibition In Vitro.
Thrombomodulin dependent protein C activation is required for mitochondrial function and myelination in the CNS.
[Evaluation of white matter myelination in preterm infants using DTI and MRI].
A nerve conduit containing a vascular bundle and implanted with bone marrow stromal cells and decellularized allogenic nerve matrix.
Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists.
Teaching Video NeuroImages: Primary writing tremor: Lessons from a patient with multiple sclerosis.
Brain stiffness increases with myelin content.
Learning to live with multiple sclerosis cognitive impairment and how it influences readiness for group cognitive intervention.
Preclinical Metabolism, Pharmacokinetics and In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy.
Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.
Autoantibodies to heterogeneous nuclear ribonuclear protein A1 (hnRNPA1) cause altered 'ribostasis' and neurodegeneration; the legacy of HAM/TSP as a model of progressive multiple sclerosis.
Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy.
Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
Combination treatment of fingolimod with antidepressants in relapsing-remitting multiple sclerosis patients with depression: a multicentre, open-label study - REGAIN.
The history of myelin.
Multiple sclerosis: Dehydration might contribute to fatigue in MS.
"Venous congestion" as a cause of subcortical white matter T2 hypointensity on magnetic resonance images.
Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders.
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.
Pages
« first
‹ previous
…
731
732
733
734
735
736
737
738
739
…
next ›
last »